When.com Web Search

  1. Ads

    related to: domperidone and depression

Search results

  1. Results From The WOW.Com Content Network
  2. Domperidone - Wikipedia

    en.wikipedia.org/wiki/Domperidone

    Domperidone, sold under the brand name Motilium among others, is a dopamine antagonist medication which is used to treat nausea and vomiting and certain gastrointestinal problems like gastroparesis (delayed gastric emptying).

  3. Dopamine antagonist - Wikipedia

    en.wikipedia.org/wiki/Dopamine_antagonist

    Dopamine receptor flow chart. Dopamine receptors are all G protein–coupled receptors, and are divided into two classes based on which G-protein they are coupled to. [1] The D 1-like class of dopamine receptors is coupled to Gα s/olf and stimulates adenylate cyclase production, whereas the D 2-like class is coupled to Gα i/o and thus inhibits adenylate cyclase production.

  4. List of antidepressants - Wikipedia

    en.wikipedia.org/wiki/List_of_antidepressants

    This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification.

  5. Deudomperidone - Wikipedia

    en.wikipedia.org/wiki/Deudomperidone

    Deudomperidone (developmental code name CIN-102; also known as deuterated domperidone) is a dopamine antagonist medication which is under development in the United States for the treatment of gastroparesis. [1] [2] [3] It acts as a selective dopamine D 2 and D 3 receptor antagonist and has peripheral selectivity.

  6. Study Says Step Count Can Decrease Depression - AOL

    www.aol.com/study-says-step-count-decrease...

    A 2023 Gallup survey found that self-reported rates of depression had increased by 10% between 2015 and 2023. The study also found that one in six Americans were currently in treatment for depression.

  7. Opioid - Wikipedia

    en.wikipedia.org/wiki/Opioid

    Respiratory depression is the most serious adverse reaction associated with opioid use, but it usually is seen with the use of a single, intravenous dose in an opioid-naïve patient. In patients taking opioids regularly for pain relief, tolerance to respiratory depression occurs rapidly, so that it is not a clinical problem.